# Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

> **NCT01650298** · NA · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 64 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **OTHER:** Drug (Direct thrombin or Factor Xa inhibitor)

## Key facts

- **NCT ID:** NCT01650298
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2016-12
- **Final completion:** 2017-08
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** Due to slow enrollment.
- **Last updated:** 2020-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01650298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01650298, "Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01650298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*